Skip to main content

Romina Dieli Crimi

Institutions of which they are part

Translational Immunology
Vall Hebron Institut de Recerca

Romina Dieli Crimi

Institutions of which they are part

Translational Immunology
Vall Hebron Institut de Recerca

Projects

Identification and functional characterization of structural variants in patients with inborn errors of immunity

IP: Roger Colobran Oriol
Collaborators: Romina Dieli Crimi, Aina Aguiló Cucurull, Alba Parra Martínez, Laura Batlle Masó, Andrea Martín Nalda, Neus Castells Sarret
Funding agency: Instituto de Salud Carlos III
Funding: 208750
Reference: PI23/00161
Duration: 01/01/2024 - 31/12/2026

COVID-19, PERFIL INMUNOLÓGICO DE RIESGO

IP: Ricardo Pujol Borrell
Collaborators: Manuel Hernández González, Mónica Martínez Gallo, Moisés Labrador Horrillo, Gema Codina Grau, Albert Blanco Grau, Andres Antón Pagarolas, Antonio Álvarez Fernandez, Nuria Fernández Hidalgo, Roser Ferrer Costa, Esteve Ribera Pascuet, Juan Carlos Ruiz Rodriguez, Jaume Ferrer Sancho, Anna Suy Franch, Pere Soler Palacín, Albert Selva O'Callaghan, Tomàs Pumarola Suñé, Isabel Ruiz Camps, Marta Miarons Font, Daniel Alvarez De la Sierra, Andrea Martín Nalda, Eva Polverino, Romina Dieli Crimi, Romina Dieli Crimi
Funding agency: Instituto de Salud Carlos III
Funding: 229000
Reference: COV20/00416
Duration: 08/05/2020 - 08/11/2021

Synthetic diagnostic device to substitute animal erythrocytes in classical haemagglutination assays: application to influenza virus surveillance.

IP: Eva Baldrich Rubio
Collaborators: Romina Dieli Crimi, Mónica Martínez Gallo, Andres Antón Pagarolas, Tomàs Pumarola Suñé, Cristina Andrés Vergés
Funding agency: Instituto de Salud Carlos III
Funding: 104500
Reference: DTS20/00093
Duration: 01/01/2021 - 30/06/2023

Modelo predictivo del riesgo de infección y rechazo después del trasplante renal basado en la combinadición de parámetros clínicos y biomarcadores.

IP: Francesc Moreso Mateos
Collaborators: Joana Sellarés Roig, Concepció Jacobs Cachá, Maria de Oreto Prat Canet, Manel Perelló Carrascosa, Romina Dieli Crimi, Nestor Gabriel Toapanta Gaibor, Romina Dieli Crimi
Funding agency: Instituto de Salud Carlos III
Funding: 87120
Reference: PI18/01832
Duration: 01/01/2019 - 31/12/2022

Related news

The results show that, in some patients with mutations in the X chromosome, the healthy gene is inactivated and the mutated gene manifests itself, which favors the onset of the disease.

Researchers have used an innovative protocol to identify people with this autoimmune disease who have a higher risk of cancer.

As age increases in men, the concentration of the hormone in the blood drops and this increases the likelihood of severe progression of the infection in COVID-19 patients

Related professionals

Lluc Molins Ciutat

Lluc Molins Ciutat

Administrative
Clinical Research Support Unit (USIC)
Clinical Core Facilities
Core Facilities Area
Read more
Idoia Bolinaga Ayala

Idoia Bolinaga Ayala

Predoctoral researcher
Protein kinases in cancer research
Read more
Laia Rubio Ortega

Laia Rubio Ortega

Research technician
Gene Therapy at Nervous System
Read more
Montse Rodriguez Gomez

Montse Rodriguez Gomez

Shock, Organ Dysfunction and Resuscitation
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.